Hence, in patients with DMD, dystrophin deficiency compromises the integrity of muscle cells ultimately resulting in progressive skeletal and cardiac myopathy leading to fatality, normally between the second and third decades of life2, 6. This evidence concerns the gene DMD and Duchenne muscular dystrophy.